[Nphe1,Arg14,Lys15]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray

European Journal of Pharmacology

Volumn 515, Issue 1-3, 2005, Pages 47-53

  Chiou, Lih Chu ^a   Liao, Yan Yu ^a   Guerrini, Remo ^b   Calo', Girolamo ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Nphe1,Arg14,Lys15 N OFQ NH2; Nociceptin; NOP receptor; Orphanin FQ; Periaqueductal gray; Potassium channel; UFP 101

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR AGONIST; NOCICEPTIN DERIVATIVE; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR ANTAGONIST; NOCICEPTIN[1 NORPHENYLALANINE 14 ARGININE 15 LYSINE]AMIDE; POTASSIUM CHANNEL; UFP 101; UNCLASSIFIED DRUG; (NPHE(1),ARG(14),LYS(15))N OFQ NH(2); (NPHE(1),ARG(14),LYS(15))N-OFQ NH(2); INWARDLY RECTIFYING POTASSIUM CHANNEL; NOCICEPTIN; OPIATE PEPTIDE; OPIATE RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; MEMBRANE CURRENT; MESENCEPHALON; NERVE CELL; NONHUMAN; PAIN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; ANIMAL; BINDING COMPETITION; CELL MEMBRANE POTENTIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BINDING, COMPETITIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; MEMBRANE POTENTIALS; NEURONS; OPIOID PEPTIDES; PERIAQUEDUCTAL GRAY; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, WISTAR; RECEPTORS, OPIOID;

EID: 20344408530     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.03.036     Document Type: Article

References (44)

1. B. Anton, J. Fein, T. To, X. Li, L. Silberstein, and C.J. Evans Immunohistochemical localization of ORL-1 in the central nervous system of the rat J. Comp. Neurol. 368 1996 229 251
2. J.A. Becker, A. Wallace, A. Garzon, P. Ingallinella, E. Bianchi, R. Cortese, F. Simonin, B.L. Kieffer, and A. Pessi Ligands for kappa-opioid and ORL1 receptors identified from a conformationally constrained peptide combinatorial library J. Biol. Chem. 274 1999 27513 27522
3. M.M. Behbehani Functional characteristics of the midbrain periaqueductal gray Prog. Neurobiol. 46 1995 575 605
4. M.M. Behbehani, M. Jiang, and S.D. Chandler The effect of [Met]enkephalin on the periaqueductal gray neurons of the rat: an in vitro study Neuroscience 38 1990 373 380
5. 2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ Br. J. Pharmacol. 126 1999 555 558
6. 2, a new selective nociceptin receptor antagonist Br. J. Pharmacol. 129 2000 1183 1193
7. G. Calo', R. Guerrini, A. Rizzi, S. Salvadori, and D. Regoli Pharmacology of nociceptin and its receptor: a novel therapeutic target Br. J. Pharmacol. 129 2000 1261 1283
8. 2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor Br. J. Pharmacol. 136 2002 303 311
9. B. Chieng, and M.J. Christie Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro Br. J. Pharmacol. 113 1994 121 128
10. L.C. Chiou Pharmacological characterization of the nociceptin receptor, ORL1. Insight from the inward rectifier activation in the periaqueductal gray J. Biomed. Sci. 7 2000 232 240
11. + channels by nociceptin and a mu-opioid in rat periaqueductal grey slices Naunyn-Schmiedeberg's Arch. Pharmacol. 363 2001 583 589
12. + channels in rat periaqueductal gray slices Neuropharmacology 42 2002 987 992
13. + channels and cellular actions of morphine in periaqueductal gray slices of neonatal and adult rats J. Pharmacol. Exp. Ther. 298 2001 493 500
14. L.C. Chiou, and L.Y. Huang Mechanism underlying increased neuronal activity in the rat ventrolateral periaqueductal grey by a mu-opioid J. Physiol. 518 2 1999 551 559
15. + channel activation in rat periaqueductal gray slices Neuropharmacology 42 2002 246 252
16. L.C. Chiou, S.H. Fan, K.C. Chuang, Y.Y. Liao, and S.Z. Lee Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray Ann. N. Y. Acad. Sci. 1025 2004 398 403
17. 2-muscarinic and GABAB-receptors increase the same potassium conductance in rat lateral parabrachial neurones Br. J. Pharmacol. 95 1988 896 902
18. T. Darland, M.M. Heinricher, and D.K. Grandy Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more Trends Neurosci. 21 1998 215 221
19. C.T. Dooley, C.G. Spaeth, I.P. Berzetei-Gurske, K. Craymer, I.D. Adapa, S.R. Brandt, R.A. Houghten, and L. Toll Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1 J. Pharmacol. Exp. Ther. 283 1997 735 741
20. M.E. Fiset, C. Gilbert, P.E. Poubelle, and M. Pouliot Human neutrophils as a source of nociceptin: a novel link between pain and inflammation Biochemistry 42 2003 10498 10505
21. E.C. Gavioli, C.W. Vaughan, G. Marzola, R. Guerrini, V.A. Mitchell, S. Zucchini, T.C. De Lima, G.A. Rae, S. Salvadori, D. Regoli, and G. Calo' Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice Naunyn-Schmiedeberg's Arch. Pharmacol. 369 2004 547 553
22. E. Hashiba, K. Hirota, T. Kudo, G. Calo', R. Guerrini, and A. Matsuki Effects of nociceptin/orphanin FQ receptor ligands on blood pressure, heart rate, and plasma catecholamine concentrations in guinea pigs Naunyn-Schmiedeberg's Arch. Pharmacol. 367 2003 342 347
23. + (GIRK) channel Brain Res. Mol. Brain Res. 45 1997 117 126
24. + channel in Xenopus oocytes Br. J. Pharmacol. 120 1997 986 987
25. M. Koizumi, K. Sakoori, N. Midorikawa, and N.P. Murphy The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism Br. J. Pharmacol. 143 2004 53 62
26. A. Kuzmin, J. Sandin, L. Terenius, and S.O. Ogren Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors Br. J. Pharmacol. 141 2004 132 140
27. M. Marti, S. Stocchi, F. Paganini, F. Mela, C. De Risi, G. Calo', R. Guerrini, T.A. Barnes, D.G. Lambert, L. Beani, C. Bianchi, and M. Morari Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex Br. J. Pharmacol. 138 2003 91 98
28. J.P. Mathis, J. Ryan-Moro, A. Chang, J.S. Hom, D.A. Scheinberg, and G.W. Pasternak Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain Biochem. Biophys. Res. Commun. 230 1997 462 465
29. J.C. Meunier, C. Mollereau, L. Toll, C. Suaudeau, C. Moisand, P. Alvinerie, J.L. Butour, J.C. Guillemot, P. Ferrara, B. Monsarrat, H. Mazarguil, G. Vassart, M. Parmentier, and J. Costentin Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor Nature 377 1995 532 535
30. J.S. Mogil, and G.W. Pasternak The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family Pharmacol. Rev. 53 2001 381 415
31. C. Mollereau, M. Parmentier, P. Mailleux, J.L. Butour, C. Moisand, P. Chalon, D. Caput, G. Vassart, and J.C. Meunier ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization FEBS Lett. 341 1994 33 38
32. M.M. Morgan, J.E. Grisel, C.S. Robbins, and D.K. Grandy Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ NeuroReport 8 1997 3431 3434
33. G. Morini, G. De Caro, R. Guerrini, M. Massi, and C. Polidori Nociceptin/orphanin FQ prevents ethanol-induced gastric lesions in the rat Regul. Pept. 124 2005 203 207
34. NC-IUPHAR, 2004. IUPHAR receptor database: opioid receptors. http://www.iuphar-db.org/iuphar-rd/.
35. H.P. Nothacker, R.K. Reinscheid, A. Mansour, R.A. Henningsen, A. Ardati, F.J. Monsma Jr., S.J. Watson, and O. Civelli Primary structure and tissue distribution of the orphanin FQ precursor Proc. Natl. Acad. Sci. U. S. A. 93 1996 8677 8682
36. K. Okada, T. Sujaku, Y. Chuman, R. Nakashima, T. Nose, T. Costa, Y. Yamada, M. Yokoyama, A. Nagahisa, and Y. Shimohigashi Highly potent nociceptin analog containing the Arg-Lys triple repeat Biochem. Biophys. Res. Commun. 278 2000 493 498
37. S. Ozaki, H. Kawamoto, Y. Itoh, M. Miyaji, T. Azuma, D. Ichikawa, H. Nambu, T. Iguchi, Y. Iwasawa, and H. Ohta In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist Eur. J. Pharmacol. 402 2000 45 53
38. J. Peluso, K.S. LaForge, H.W. Matthes, M.J. Kreek, B.L. Kieffer, and C. Gaveriaux-Ruff Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells J. Neuroimmunol. 81 1998 184 192
39. R.K. Reinscheid, H.P. Nothacker, A. Bourson, A. Ardati, R.A. Henningsen, J.R. Bunzow, D.K. Grandy, H. Langen, F.J. Monsma, and O. Civelli Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor Science 270 1995 792 794
40. 15]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies J. Pharmacol. Exp. Ther. 300 2002 57 63
41. C.N. Serhan, I.M. Fierro, N. Chiang, and M. Pouliot Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4 J. Immunol. 166 2001 3650 3654
42. C.W. Vaughan, and M.J. Christie Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro J. Physiol. 498 2 1997 463 472
43. C.W. Vaughan, S.L. Ingram, and M.J. Christie Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro J. Neurosci. 17 1997 996 1003
44. T.L. Yaksh, J.C. Yeung, and T.A. Rudy Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray Brain Res. 114 1976 83 103